Dr. Ravi Degun is a partner in the Life Science Strategy Practice, based in the UK London Office.
Ravi has more than 10 years’ experience in the Healthcare, life sciences and R&D sector, having worked in academia, government research and consulting (with Accenture, PA Consulting Group and Thomson Reuters Life Sciences Consulting). His areas of focus are market access/pricing & reimbursement, real world data collection, resource utilization, non-interventional studies, and commercial strategy for both major and emerging biological, pharmaceutical & medical-device companies, government and the European healthcare sector.
Ravi’s background is in medical research focusing on oncology, virology (HIV) and immunology, Ravi spent four years working at some of the UK's leading medical research Institutes, such as the Medical Research Councils (MRC) National Institute for Medical Research and the Veterinary Laboratories Agency (DEFRA) as well as a number of leading UK hospitals.
Ravi has a Ph.D. In HIV Vaccine Development, from the GKT Medical School, King’s College London, and a B.Sc. (Hons.) in Molecular Biology & Genetics. To compliment his scientific background, Ravi has studied business strategy at Tanaka Business School, Imperial College (London), and London Business School.
Ph.D., Vaccine Development, Faculty of Medicine, GKT Medical School, King’s College, University of London, UK M.B.A., Tanaka Business School, Imperial College, University of London, UK B.Sc., with honors, Molecular Biology & Genetics, Royal Holloway College, University of London, UK Executive Programme, Unlocking Client Strategy, London Business School, UK
European Society for Medical Oncology (ESMO) International Society For Pharmacoeconomics and Outcomes Research (ISPOR)